The Glaucoma Foundation Inc

What it reported doing in 2025

1) multiple webinars: what do cold hands have to do with glaucoma? The promise of optic nerve regeneration; the body-eye relationship how to save the sight of patients with glaucoma while minimizing adverse reaction from eye drops; insights into glaucoma & women's health: exploring the impact of menopause and visual function; glaucoma and lifestyle. 2) the optic nerve rescue and restoration think tank "a patient-centric approach while incorporating the latest science" glaucoma data integration: overview of databases available to advance glaucoma knowledge; lessons learned about glaucoma from the uk biobank; poag genomic architecture; a 360-degree biomedical profile of health: lessons from cardiovascular disease. 3) drug re-purposing in glaucoma: insulin signaling and; metformin and glaucoma; glp-1r agonists and glaucoma. 4) overview of glaucoma neuroprotection agents: why do we not have a neuroprotection agent for glaucoma? How can ai help facilitate randomized clinical trials in neuroprotection? 5) sex hormones and glaucoma: the role of sex hormones in the pathogenesis of open-angle glaucoma: evidence from epidemiological studies; estrogen signaling pathways in glaucoma; the biomechanical argument that estrogen plays a role in glaucoma; 6) non-iop factors of importance in glaucoma: diet and glaucoma; hypertension, antihypertensive drugs and glaucoma; the impact of glaucoma on activities of daily living. 7) what can tgf do to help patients, researchers, and eyecare providers tackle glaucoma?: what is the glaucoma foundation doing now? What do patients want to see in glaucoma research? 8) start with the young: info session on glaucoma for middle and high school students; in coordination with the stem institute at the city college of New York. 9) newsletters: tgf produced six electronic newsletters that were distributed to more than 16,000 households. Tgf's quarterly printed newsletters were available for constituents who do not use computers or who prefer to read paper documents. Newsletters include interviews with doctors, researchers, and patients. They cover topics such as advancements in diagnosis and treatment, perspectives on care, and personal stories of living with the disease.

Financial Efficiency

• Mission deployment rate: 47.7%; rating input score 48
• Program expense ratio: 77.6%; rating input score 78
• Fundraising efficiency: $14.64 raised per $1 spent on fundraising; rating input score 49; 49th percentile among comparable filings

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
• Pay-setting controls: 3 of 6 controls in place; rating input score 50
  • Compensation committee: Missing
  • Independent consultant: Missing
  • Other Form 990s reviewed: Pass
  • Written employment contract: Missing
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: 1 of 8 controls in place; rating input score 12
  • Claims monitoring procedures: Pass
  • Requires narrative reports: Fail
  • Conducts field audits: Fail
  • May suspend future funding: Fail
  • Requires financial reports: Fail
  • Conducts site visits: Fail
  • Requires grant agreements: Fail
  • May require repayment: Fail
• Grant itemization coverage: 100%; rating input score 100; 75th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 48.7%; rating input score 90; 90th percentile among comparable filings
• Total-asset coverage ratio: 6.78; rating input score 85; 85th percentile among comparable filings
• Liabilities to assets ratio: 0.07; rating input score 54; 54th percentile among comparable filings
• Officer compensation ratio: 24.6%; rating input score 11; 11th percentile among comparable filings

Growth

• Program expense growth: 9.8% per year; rating input score 100; 60th percentile among comparable filings
• Revenue growth: 12.5% per year; rating input score 100; 74th percentile among comparable filings
• Asset growth: 12.6% per year; rating input score 100; 67th percentile among comparable filings